FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18360011000001107: Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jan 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62748801000001113 Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62748901000001119 Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Is a Risedronate sodium 30mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Has AMP Risedronate sodium 30mg tablets (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Risedronate sodium true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Risedronate sodium 30mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start